Resveratrol protects against high-fat diet induced renal pathological damage and cell senescence by activating SIRT1

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 9, 2016, Pages 1448-1454

  Zhang, Nannan ^a   Li, Zhongchi ^a   Xu, Kang ^a   Wang, Yanying ^a,b   Wang, Zhao ^a  

^a Tsinghua University   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Kidney; Pathology; Resveratrol; Senescence; SIRT1

Indexed keywords

BETA GALACTOSIDE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GLUCOSE; RESVERATROL; SIRTUIN 1; SUPEROXIDE DISMUTASE; PROTECTIVE AGENT; SIRT1 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAGING ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALORIC RESTRICTION; CELL AGING; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RENAL PROTECTION; TREATMENT DURATION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOLOGY;

ANIMALS; CELL AGING; DIET, HIGH-FAT; KIDNEY; MALE; MICE, INBRED C57BL; PROTECTIVE AGENTS; SIRTUIN 1; STILBENES;

EID: 84984682164     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b16-00085     Document Type: Article

References (48)

1. Zibellini J, Seimon RV, Lee CM, Gibson AA, Hsu MS, Shapses SA, Nguyen TV, Sainsbury A. Does diet-induced weight loss lead to bone loss in overweight or obese adults? A systematic review and meta-analysis of clinical trials. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 30, 2168-2178 (2015).
2. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U.S.A., 105, 9793-9798 (2008).
3. Altunkaynak ME, Ozbek E, Altunkaynak BZ, Can I, Unal D, Unal B. The effects of high-fat diet on the renal structure and morphometric parametric of kidneys in rats. J. Anat., 212, 845-852 (2008).
4. Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Kubota N, Terauchi Y, Kadowaki T, Haneda M, Kashiwagi A, Koya D. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol., 18, 2715-2723 (2007).
5. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol., 296, F118-F126 (2008).
6. Guarente L, Picard F. Calorie restriction - the SIR2 connection. Cell, 120, 473-482 (2005).
7. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J., 404, 1-13 (2007).
8. He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM. Sirt1 activation protects the mouse renal medulla from oxidative injury. J. Clin. Invest., 120, 1056-1068 (2010).
9. Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, Cohen RA, Zang M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem., 283, 20015-20026 (2008).
10. Kitada M, Kume S, Imaizumi N, Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes, 60, 634-643 (2011).
11. Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biol. Pharm. Bull., 35, 273-279 (2012).
12. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450, 712-716 (2007).
13. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 5, 493-506 (2006).
14. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342 (2006).
15. 3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem. Biophys. Res. Commun., 354, 45-49 (2007).
16. Blazer S, Khankin E, Segev Y, Ofir R, Yalon-Hacohen M, Kra- Oz Z, Gottfried Y, Larisch S, Skorecki KL. High glucose-induced replicative senescence: point of no return and effect of telomerase. Biochem. Biophys. Res. Commun., 296, 93-101 (2002).
17. Kim YJ, Hwang SH, Lee SY, Shin KK, Cho HH, Bae YC, Jung JS. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev., 21, 1749-1760 (2012).
18. Walker JM. The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol. Biol., 32, 5-8 (1994).
19. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest., 74, 1156-1164 (1984).
20. Hill GS, Heudes D, Bariety J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int., 63, 1027-1036 (2003).
21. El Nahas AM, Muchaneta-Kubara EC, Essaway M, Soylemezoglu O. Renal fibrosis: insights into pathogenesis and treatment. Int. J. Biochem. Cell Biol., 29, 55-62 (1997).
22. Ksiażek K, Breborowicz A, Jorres A, Witowski J. Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic. Biol. Med., 42, 636-641 (2007).
23. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peaocke M., Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A., 92, 9363-9367 (1995).
24. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest., 114, 1299-1307 (2004).
25. Genkinger JM, Platz EA, Hoffman SC, Strickland P, Huang HY, Comstock GW, Helzlsouer KJ. C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival. Mech. Ageing Dev., 127, 371-377 (2006).
26. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res., 100, 1512-1521 (2007).
27. Guarente L. Calorie restriction and sirtuins revisited. Genes Dev., 27, 2072-2085 (2013).
28. Wang Z, Zhang L, Liang Y, Zhang C, Xu Z, Zhang L, Fuji R, Mu W, Li L, Jiang J, Ju Y, Wang Z. Cyclic AMP mimics the anti-ageing effects of calorie restriction by up-regulating Sirtuin. Scientific Reports, 5, 12012 (2015).
29. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science, 289, 2126-2128 (2000).
30. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 305, 390-392 (2004).
31. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, Steele AD, Crowe H, Marmor S, Luo J, Gu W, Guarente L. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell, 6, 759-767 (2007).
32. Vial G, Dubouchaud H, Couturier K, Cottet-Rousselle C, Taleux N, Athias A, Galinier A, Casteilla L, Leverve XM. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J. Hepatol., 54, 348-356 (2011).
33. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal., 24, 981-990 (2012).
34. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev., 94, 909-950 (2014).
35. Holley AK, Dhar SK, St. Clair DK. Manganese superoxide dismutase vs. p53: regulation of mitochondrial ROS. Mitochondrion, 10, 649-661 (2010).
36. Du Z, Yang Y, Hu Y, Sun Y, Zhang S, Peng W, Zhong Y, Huang X, Kong W. A long-term high-fat diet increases oxidative stress, mitochondrial damage and apoptosis in the inner ear of D-galactose-induced aging rats. Hear. Res., 287, 15-24 (2012).
37. Fan Y, Qiao Y, Huang J, Tang M. Protective effects of Panax notoginseng saponins against high glucose-induced oxidative injury in rat retinal capillary endothelial cells. Evid. Based Complement. Alternat. Med., 2016, 5326382 (2016).
38. Bhat NR, Thirumangalakudi L. Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. JAD, 36, 781-789 (2013).
39. Grzelkowska-Kowalczyk K, Wieteska W. The impairment of IGF-I-stimulated protein synthesis and activation of protein kinase B, p70(S6k), MAP kinase, and p90(rsk) in mouse C2C12 myogenic cells exposed to high glucose and high insulin. Pol. J. Vet. Sci., 8, 241-250 (2005).
40. Homayounfar R, Jeddi-Tehrani M, Cheraghpour M, Ghorbani A, Zand H. Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic and oncogenic signaling of insulin. Gen. Comp. Endocrinol., 214, 134-139 (2015).
41. Song J, Lee B, Kang S, Oh Y, Kim E, Kim CH, Song HT, Lee JE. Agmatine ameliorates high glucose-induced neuronal cell senescence by regulating the p21 and p53 signaling. Exp. Neurobiol., 25, 24-32 (2016).
42. Szalay CI, Erdelyi K, Kokeny G, Lajtar E, Godo M, Revesz C, Kaucsar T, Kiss N, Sarkozy M, Csont T, Krenacs T, Szenasi G, Pacher P, Hamar P. Oxidative/nitrative stress and inflammation drive progression of doxorubicin-induced renal fibrosis in rats as revealed by comparing a normal and a fibrosis-resistant rat strain. PLoS ONE, 10, e0127090 (2015).
43. Baud L, Fouqueray B, Bellocq A. Inflammatory mechanisms of renal fibrosis: glomerulonephritis. Bull. Acad. Natl. Med., 183, 23-31 (1999).
44. Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol., 10, 493-503 (2014).
45. Jha JC, Banal C, Chow BS, Cooper ME, Jandeleit-Dahm KA. Diabetes and kidney disease: Role of oxidative stress. Antioxid. Redox Signal. (2016). DOI: 10.1089/ars.2016.6664
46. Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant mechanisms in renal injury and disease. Antioxid. Redox Signal., (2016).
47. Small DM, Bennett NC, Roy S, Gabrielli BG, Johnson DW, Gobe GC. Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease. Nephron. Exp. Nephrol., 122, 123-130 (2012).
48. Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int., 65, 510-520 (2004).